联合连接组学、MAPT基因表达与淀粉样蛋白沉积解释阿尔茨海默病区域性tau沉积
研究纳入3项研究共685名参与者(395名淀粉样蛋白阳性AD谱系患者和290名淀粉样蛋白阴性对照),利用静息态功能连接、MAPT基因表达和淀粉样蛋白PET预测tau-PET的区域分布。结果显示,联合三种模态较单一模态显著提高了解释方差,为解释AD中tau沉积的区域易感性提供了工具。
要点
- 在淀粉样蛋白阳性参与者中,功能连接单独解释tau-PET区域值方差的21.8%至39.2%(范围跨3项研究)。
- 逐步加入MAPT基因表达和淀粉样蛋白PET后,解释方差分别提高至30.2%至46.0%和45.0%至49.9%。
- 联合三种预测因子对患者个体水平tau-PET区域值的解释方差(平均调整R²范围跨研究)为0.251至0.333,高于连接单独(0.118至0.148)和连接加MAPT表达(0.156至0.196)。
核心结论
- 在3个研究样本中,联合功能连接组和分子特征较单一模态大幅提升了解释力,为解释AD中tau沉积的区域易感性提供了有价值的工具。
研究设计与样本
- 研究纳入685名参与者(395名淀粉样蛋白阳性AD谱系参与者和290名淀粉样蛋白阴性对照),来自3项研究(阿尔茨海默病神经影像学倡议、18F-AV-1451-A05和BioFINDER-1),均具有tau-PET和淀粉样蛋白PET数据。
- 从人类连接组计划健康对照(n=1,000)获取静息态功能磁共振成像,从艾伦人脑图谱获取MAPT基因表达。
- 基于叠加于所有模态的脑分区图谱,获取感兴趣区(ROI)间功能连接、ROI水平PET值和MAPT基因表达;采用逐步回归分析检验连接、MAPT基因表达和淀粉样蛋白PET对淀粉样蛋白阳性参与者组平均和个体tau-PET ROI值的预测作用。
主要发现
- 连接单独解释淀粉样蛋白阳性参与者组平均tau-PET ROI值方差的21.8%至39.2%(范围跨3项研究)。
- 逐步加入MAPT基因表达和淀粉样蛋白PET后,解释方差分别提高至30.2%至46.0%和45.0%至49.9%。
- 对患者个体水平tau-PET ROI值的预测,联合所有3种预测因子显著改善了解释的变异(平均调整R²范围跨研究:连接单独为0.118-0.148,连接加MAPT表达为0.156-0.196,三种模态联合为0.251-0.333)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to test whether region-specific factors, including spatial expression patterns of the tau-encoding gene MAPT and regional levels of amyloid positron emission tomography (PET), enhance connectivity-based modeling of the spatial variability in tau-PET deposition in the Alzheimer disease (AD) spectrum. METHODS: We included 685 participants (395 amyloid-positive participants within AD spectrum and 290 amyloid-negative controls) with tau-PET and amyloid-PET from 3 studies (Alzheimer's Disease Neuroimaging Initiative, 18 F-AV-1451-A05, and BioFINDER-1). Resting-state functional magnetic resonance imaging was obtained in healthy controls (n = 1,000) from the Human Connectome Project, and MAPT gene expression from the Allen Human Brain Atlas. Based on a brain-parcellation atlas superimposed onto all modalities, we obtained region of interest (ROI)-to-ROI functional connectivity, ROI-level PET values, and MAPT gene expression. In stepwise regression analyses, we tested connectivity, MAPT gene expression, and amyloid-PET as predictors of group-averaged and individual tau-PET ROI values in amyloid-positive participants. RESULTS: Connectivity alone explained 21.8 to 39.2% (range across 3 studies) of the variance in tau-PET ROI values averaged across amyloid-positive participants. Stepwise addition of MAPT gene expression and amyloid-PET increased the proportion of explained variance to 30.2 to 46.0% and 45.0 to 49.9%, respectively. Similarly, for the prediction of patient-level tau-PET ROI values, combining all 3 predictors significantly improved the variability explained (mean adjusted R2 range across studies = 0.118-0.148, 0.156-0.196, and 0.251-0.333 for connectivity alone, connectivity plus MAPT expression, and all 3 modalities combined, respectively). INTERPRETATION: Across 3 study samples, combining the functional connectome and molecular properties substantially enhanced the explanatory power compared to single modalities, providing a valuable tool to explain regional susceptibility to tau deposition in AD. ANN NEUROL 2024;95:274-287.
引用
- Zheng L, Rubinski A, Denecke J, et al. Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease. Ann Neurol. 2023. PMID: 37837382. doi:10.1002/ana.26818
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。